Anzahl der Publikationen: 6
Zeitschriftenartikel
Rothenburger, Tamara; Thomas, Dominique; Schreiber, Yannick; Wratil, Paul R.; Pflantz, Tamara; Knecht, Kirsten; Digianantonio, Katie; Temple, Joshua; Schneider, Constanze; Baldauf, Hanna-Mari; McLaughlin, Katie-May; Rothweiler, Florian; Bilen, Berna; Farmand, Samira; Bojkova, Denisa; Costa, Rui; Ferreiros, Nerea; Geisslinger, Gerd; Oellerich, Thomas; Xiong, Yong; Keppler, Oliver T.; Wass, Mark N.; Michaelis, Martin und Cinatl, Jindrich
(2021):
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.
In: Journal of Experimental & Clinical Cancer Research, Bd. 40, Nr. 1, 317
Rothenburger, Tamara; McLaughlin, Katie-May; Herold, Tobias; Schneider, Constanze; Oellerich, Thomas; Rothweiler, Florian; Feber, Andrew; Fenton, Tim R.; Wass, Mark N.; Keppler, Oliver T.; Michaelis, Martin und Cinatl, Jindrich
(2020):
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.
In: Communications Biology, Bd. 3, Nr. 1
Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; Knecht, Kirsten M.; Buzovetsky, Olga; Kaderali, Lars; Schliemann, Christoph; Bohnenberger, Hanibal; Angenendt, Linus; Hartmann, Wolfgang; Wardelmann, Eva; Rothenburger, Tamara; Mohr, Sebastian; Scheich, Sebastian; Comoglio, Federico; Wilke, Anne; Stroebel, Philipp; Serve, Hubert; Michaelis, Martin; Ferreiros, Nerea; Geisslinger, Gerd; Xiong, Yong; Keppler, Oliver T. und Cinatl, Jindrich
(2019):
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
In: Nature Communications, Bd. 10, 3475
[PDF, 2MB]
The Duy, Nguyen; Shaid, Shabnam; Vakhrusheva, Olesya; Koschade, Sebastian E.; Klann, Kevin; Thoelken, Marlyn; Baker, Fatima; Zhang, Jing; Oellerich, Thomas; Sueruen, Duran; Derlet, Anja; Haberbosch, Isabella; Eimer, Stefan; Osiewacz, Heinz D.; Behrends, Christian; Muench, Christian; Dikic, Ivan und Brandts, Christian H.
(2019):
Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy.
In: Blood, Bd. 133, Nr. 2: S. 168-179
Bohnenberger, Hanibal; Kaderali, Lars; Stroebel, Philipp; Yepes, Diego; Plessmann, Uwe; Dharia, Neekesh V.; Yao, Sha; Heydt, Carina; Merkelbach-Bruse, Sabine; Emmert, Alexander; Hoffmann, Jonatan; Bodemeyer, Julius; Reuter-Jessen, Kirsten; Lois, Anna-Maria; Dröge, Leif Hendrik; Baumeister, Philipp; Walz, Christoph; Biggemann, Lorenz; Walter, Roland; Häupl, Björn; Comoglio, Federico; Pan, Kuan-Ting; Scheich, Sebastian; Lenz, Christof; Kueffer, Stefan; Bremmer, Felix; Kitz, Julia; Sitte, Maren; Beissbarth, Tim; Hinterthaner, Marc; Sebastian, Martin; Lotz, Joachim; Schildhaus, Hans-Ulrich; Wolff, Hendrik; Danner, Bernhard C.; Brandts, Christian; Büttner, Reinhard; Canis, Martin; Stegmaier, Kimberly; Serve, Hubert; Urlaub, Henning und Oellerich, Thomas
(2018):
Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis.
In: EMBO Molecular Medicine, Bd. 10, Nr. 9, e8428
[PDF, 1MB]
Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T. und Cinatl, Jindrich
(2017):
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
In: Nature Medicine, Bd. 23, Nr. 2: S. 250-255
Diese Liste wurde am
Sat Nov 16 22:15:08 2024 CET
erstellt.